期刊文献+

多囊卵巢综合征孕妇并发妊娠期糖代谢异常的相关因素探讨 被引量:7

Associated factors of gestational diabetes mellitus(GDM) and gestational impaired glucose tolerance in pregnant women with polycystic ovarian syndrome
原文传递
导出
摘要 目的:分析多囊卵巢综合征孕妇妊娠期糖代谢异常的发病情况以及与发病相关的因素。方法:回顾性分析300例孕妇的病历资料,其中多囊卵巢综合征(PCOS)组140人,正常孕妇160人。结果:PCOS组妊娠期糖代谢异常发生率为60.71%(85/140),其中妊娠期糖尿病(GDM)45例,妊娠期糖耐量受损(GIGT)40例;对照组孕期发生妊娠期糖代谢异常发生率为18.75%(30/160),其中妊娠期糖尿病(GDM)13例,妊娠期糖耐量受损(GIGT)17例。两组间比较有显著性差异(P<0.05)。结论:多囊卵巢综合征患者由于存在胰岛素抵抗(IR),易导致糖代谢异常而引发妊娠期糖代谢异常,且肥胖加剧胰岛素抵抗的程度,因此对此类患者应加强预防性监控。 Objective: To investigate the incidence and associated factors of gestational diabetes mellitus (GDM) and gestational impaired glucose tolerance (GIGT) in pregnant women with polycystic ovarian syndrome (PCOS) . Methods: A retrospective study was conducted on 300 pregnant women from 2001 to 2007 in this hospital. All these women were divided into 2 groups : normal pregnant women without PCOS (total 160) and pregnant women with PCOS ( total 140), to investigate the incidence and associated factors of GDM and GIGT. Results: Control group had GDM or GIGT, the incidence was 18. 75% ; and 85 cases of the trial group had GDM (45) or GIGT (40), the incidence was 60. 71%, the morbidity was significantly higher than that of control group. There were significant differences between two groups (P 〈 0. 05 ) . Conclusion: As insulin resistance (IR) in patients with PCOS, which easily leads to abnormal glucose metabolism, and obesity increases the degree of IR, so the the preventive monitoring on corresponding patients should be strengthened.
出处 《中国妇幼保健》 CAS 北大核心 2008年第29期4115-4116,共2页 Maternal and Child Health Care of China
基金 广东省科技计划项目(2006B3590101)
关键词 多囊卵巢综合征 妊娠期糖尿病 胰岛素抵抗 妊娠期糖耐量受损 Polycystic ovarian syndrome (PCOS) Gestational diabetes mellitus (GDM) Insulin resistance (IR) Glucose metabolism disorders
  • 相关文献

参考文献7

二级参考文献59

  • 1张荣君,申彩霞.妊娠合并糖尿病胎儿畸形21例临床分析[J].中国优生与遗传杂志,2005,13(4):94-94. 被引量:6
  • 2曹筱佩,中华妇产科杂志,1998年,33卷,80页
  • 3Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril, 2002, 77:1095-1105.
  • 4Glueck C J, Phillips H, Cameron D, et al. Continuing metformin through pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous obortion: a pilot study. Fertil Steril,2001, 75:47-51.
  • 5John NE. Lnsulin resistance and the polycystic ovary syndrome: recent advances. Cur Opini Endocrinol Diabetes, 2000, 7(6): 345-349.
  • 6Glueck C J, Wang P, Smith S, et al. Meteformin-induced resumption of normal menses in 39 of 43 (91%)previously amenorrheic women with polycystic ovary syndrome. Metabolism, 1999, 48:511-519.
  • 7Glueck CJ, Wang P, Fontaine RN, et al. Plasminogen activator inhibitor activity:an independent risk factor for the high miscarrige rate during pregnancy in women with polycystic ovary syndrome. Metabolism,1999, 48:1589-1595.
  • 8Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril,2002, 78:487-490.
  • 9Schachter M, Raziel A, Friedler S, et al. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod, 2003, 18:721-727.
  • 10Glueck CJ, Goldenberg N, Wang P, et al. Metformin during pregnancy reduces insulin,insulin resistance,insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod, 2004, 19(3):510-521.

共引文献51

同被引文献80

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部